ArticleJournal of neuroimmunology2023

A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.

Angela Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.